PL2114441T3 - Zastosowanie fosfatazy alkalicznej w zmniejszonej funkcji nerek - Google Patents

Zastosowanie fosfatazy alkalicznej w zmniejszonej funkcji nerek

Info

Publication number
PL2114441T3
PL2114441T3 PL08705122T PL08705122T PL2114441T3 PL 2114441 T3 PL2114441 T3 PL 2114441T3 PL 08705122 T PL08705122 T PL 08705122T PL 08705122 T PL08705122 T PL 08705122T PL 2114441 T3 PL2114441 T3 PL 2114441T3
Authority
PL
Poland
Prior art keywords
treatment
alkaline phosphatase
renal function
reduced renal
reduced
Prior art date
Application number
PL08705122T
Other languages
English (en)
Inventor
Roelof Peter Pickkers
Suzanne Heemskerk
Markwin Paul Velders
Willem Raaben
Marty Bernardus Fransiscus Wulferink
Original Assignee
Am Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Am Pharma Bv filed Critical Am Pharma Bv
Publication of PL2114441T3 publication Critical patent/PL2114441T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
    • C12Y301/03001—Alkaline phosphatase (3.1.3.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
PL08705122T 2007-01-30 2008-01-30 Zastosowanie fosfatazy alkalicznej w zmniejszonej funkcji nerek PL2114441T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07101437A EP1952823A1 (en) 2007-01-30 2007-01-30 The use of alkaline phosphatase in the treatment of reduced renal function
PCT/NL2008/050053 WO2008094037A1 (en) 2007-01-30 2008-01-30 The use of alkaline phosphatase in the treatment of reduced renal function
EP08705122A EP2114441B1 (en) 2007-01-30 2008-01-30 The use of alkaline phosphatase in the treatment of reduced renal function

Publications (1)

Publication Number Publication Date
PL2114441T3 true PL2114441T3 (pl) 2013-03-29

Family

ID=38002159

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08705122T PL2114441T3 (pl) 2007-01-30 2008-01-30 Zastosowanie fosfatazy alkalicznej w zmniejszonej funkcji nerek

Country Status (11)

Country Link
US (1) US8586032B2 (pl)
EP (2) EP1952823A1 (pl)
JP (2) JP5580052B2 (pl)
CN (3) CN104189896A (pl)
AU (1) AU2008211829B2 (pl)
CA (1) CA2676968C (pl)
DK (1) DK2114441T3 (pl)
ES (1) ES2397293T3 (pl)
HK (2) HK1204925A1 (pl)
PL (1) PL2114441T3 (pl)
WO (1) WO2008094037A1 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2005210581B2 (en) 2004-02-04 2010-06-24 Am-Pharma B.V. Use of alkaline phosphatase for the detoxification of LPS present at mucosal barriers
US20110142817A1 (en) * 2004-02-04 2011-06-16 Pharmaaware Sepsis B.V. Means and method for treating and/or preventing necrotizing enterocolitis
EP1952823A1 (en) 2007-01-30 2008-08-06 AM-Pharma B.V. The use of alkaline phosphatase in the treatment of reduced renal function
EP1985697A1 (en) * 2007-04-27 2008-10-29 AM-Pharma B.V. Modified phosphatases
CA2732438A1 (en) 2008-08-29 2010-03-04 The General Hospital Corporation Methods of modulating gastrointestinal tract flora levels with alkaline phosphatase
CA2735590A1 (en) * 2008-08-29 2010-03-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2011100543A2 (en) 2010-02-12 2011-08-18 The General Hospital Corporation Methods of reducing or inhibiting toxic effects associated with a bacterial infection using alkaline phosphatase
BR112013015392A2 (pt) 2010-12-20 2016-09-20 Koninkl Philips Electronics Nv dispositivo de interface de paciente e método de prender um dispositivo de interface de paciente à cabeça de um paciente
DK2717906T5 (en) * 2011-06-08 2017-06-19 Am-Pharma B V APPLICATION OF ALKALISK PHOSPHATASE FOR THE CONSERVATION OF Kidney Function
WO2015112017A1 (en) 2014-01-24 2015-07-30 Am-Pharma B.V. Chimeric alkaline phosphatase-like proteins
DK3461891T3 (da) * 2014-01-24 2020-08-10 Am-Pharma Bv Nedstrømsbehandling af en alkalisk phosphatase
WO2018175413A1 (en) 2017-03-21 2018-09-27 Synthetic Biologics, Inc. Alkaline phosphatase formulations
AU2019207600B2 (en) 2018-01-09 2025-01-09 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of neurodevelopmental disorders
DK3762018T3 (da) 2018-03-08 2024-05-06 Am Pharma Bv Rekombinant alkalisk phosphatase til anvendelse i behandling af sepsis-forbundet akut nyrelæsion
EP4275761A3 (en) 2018-03-20 2024-02-28 Theriva Biologics, Inc. Alkaline phosphatase agents for treatment of radiation disorders
EP3768302B1 (en) 2018-03-20 2025-05-07 Theriva Biologics, Inc. Intestinal alkaline phosphatase formulations
WO2020227263A1 (en) 2019-05-06 2020-11-12 Synthetic Biologics, Inc. Alkaline phosphate-based oncology treatments
EP3975999A4 (en) 2019-06-03 2023-07-19 Theriva Biologics, Inc. ALKALINE PHOSPHATASE FORMULATIONS AND THEIR USES
CN112760305B (zh) * 2021-01-25 2022-04-29 浙江工业大学 一种栖热腔菌磷酸酶突变体及其应用
CN115990245B (zh) * 2022-07-15 2025-04-01 中山大学附属第一医院 一种含肠型碱性磷酸酶的抗腹膜纤维化透析液的制备方法
CN121038803A (zh) * 2023-03-21 2025-11-28 安-法玛公司 用于治疗慢加急性肾损伤的碱性磷酸酶

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690941B2 (en) * 1993-11-15 1998-05-07 Celtrix Pharmaceuticals, Inc. Method of treating renal disease by administering IGF-I and IGFBP-3
ATE327751T1 (de) * 2000-01-31 2006-06-15 Pfizer Prod Inc Verwendung von aktivatoren des prostaglandinrezeptores 4 zur behandlung von akuter oder chronischer niereninsuffizienz
CN1425766A (zh) 2001-12-19 2003-06-25 复旦大学 一种多肽——人含碱性磷酸酶活性位点的蛋白－9.24和编码这种多肽的多核苷酸
US7048914B2 (en) * 2002-12-12 2006-05-23 Zoltan Laboratories Placental alkaline phosphatase to control diabetes
AU2005210581B2 (en) * 2004-02-04 2010-06-24 Am-Pharma B.V. Use of alkaline phosphatase for the detoxification of LPS present at mucosal barriers
EP1952823A1 (en) 2007-01-30 2008-08-06 AM-Pharma B.V. The use of alkaline phosphatase in the treatment of reduced renal function

Also Published As

Publication number Publication date
EP2114441A1 (en) 2009-11-11
CN101678085A (zh) 2010-03-24
CN104189896A (zh) 2014-12-10
JP5580052B2 (ja) 2014-08-27
CN106466476A (zh) 2017-03-01
JP2014139202A (ja) 2014-07-31
JP5734482B2 (ja) 2015-06-17
ES2397293T3 (es) 2013-03-06
EP2114441B1 (en) 2012-10-17
CA2676968A1 (en) 2008-08-07
US20100111923A1 (en) 2010-05-06
DK2114441T3 (da) 2013-01-21
AU2008211829A1 (en) 2008-08-07
HK1232161A1 (zh) 2018-01-05
CA2676968C (en) 2015-06-16
WO2008094037A1 (en) 2008-08-07
EP1952823A1 (en) 2008-08-06
JP2010516808A (ja) 2010-05-20
AU2008211829B2 (en) 2012-09-13
HK1204925A1 (en) 2015-12-11
US8586032B2 (en) 2013-11-19

Similar Documents

Publication Publication Date Title
EG26985A (en) Zoned topsheet
ZA200900305B (en) Dressing
DK2114441T3 (da) Anvendelse af alkalisk phosphatase i behandling af nedsat nyrefunktion
IL211079A0 (en) Zoned topsheet
GB0723874D0 (en) Dressing
GB0701426D0 (en) Compounds and their use
GB0700580D0 (en) Use
PL2036882T3 (pl) Związki o jonach obojnaczych i ich zastosowanie
PL2178568T3 (pl) Środki cieniujące
GB0714670D0 (en) Use
HUE037109T2 (hu) Endoxifén rák kezelésében történõ alkalmazásra
GB0712503D0 (en) Use
EP2174629A4 (en) BUFFER
GB0610553D0 (en) Dressing
GB0705923D0 (en) Dressing
GB0608444D0 (en) Dialysis
GB0605107D0 (en) Use
GB0624105D0 (en) Use
GB0623196D0 (en) Dressing
GB0717543D0 (en) Bougie
GB0608402D0 (en) Thyroid treatment
GB0701096D0 (en) Use
PL380417A1 (pl) Opatrunek
AU318775S (en) Tampon
GB0713009D0 (en) Napkin